FDG-PET for Early Response Assessment in Lymphomas PART 1: Hodgkin Lymphoma

被引：0
|
作者：
Cheson, Bruce D. [1 ,2 ,3 ,4 ]
Kostakoglu, Lale [5 ,6 ,7 ]
机构：
[1] Georgetown Lombardi Comprehens Canc Ctr, Med, Washington, DC 20523 USA
[2] Georgetown Lombardi Comprehens Canc Ctr, Hematol, Washington, DC 20523 USA
[3] Georgetown Lombardi Comprehens Canc Ctr, Div Hematol Oncol, Washington, DC 20523 USA
[4] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20523 USA
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[6] Icahn Sch Med Mt Sinai, Nucl Med & Mol Imaging, New York, NY 10029 USA
[7] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA
来源：
ONCOLOGY-NEW YORK | 2017年 / 31卷 / 01期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; INTERIM-PET; PROGNOSTIC VALUE; INTERPRETATION CRITERIA; RADIATION-THERAPY; PREDICT RESPONSE; CELL LYMPHOMA; FREE SURVIVAL; F-18-FDG PET; CYCLES;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Interim positron emission tomography (PET)/CT has shown encouraging results when used as a prognostic tool early in the course of treatment of advanced Hodgkin lymphoma, allowing for a reduction in treatment for patients with favorable characteristics, while suggesting a benefit from changing therapy for those with a positive scan. For patients with limited disease, a negative scan allows for a decrease in treatment; however, the benefits for those patients whose scans are positive are less certain. Here we critically analyze the role of PET/CT in the early assessment of Hodgkin lymphoma. In Part 2, we will review the role of interim PET/CT in diffuse large B-cell lymphoma (DLBCL), and also explore the question of whether new approaches to quantitative assessment improve the prognostic value of interim PET scans in both Hodgkin lymphoma and DLBCL.
引用
收藏
页码：45 / 49
页数：5
相关论文
共 50 条
  • [31] Role of FDG-PET/CT in management of Hodgkin’s lymphoma
    Arun Kumar Gupta
    Devasenathipathy Kandasamy
    Rachna Seth
    The Indian Journal of Pediatrics, 2009, 76 : 1273 - 1274
  • [32] FDG-PET in lymphoma
    Michel Meignan
    Cancer Imaging, 14 (Suppl 1)
  • [33] Early assessment of response to chemotherapy by FDG-PET is highly predictive of outcome in patients with high-grade non Hodgkin's lymphoma (NHL).
    Jerusalem, G
    Najjar, F
    Paulus, P
    Beguin, Y
    Fassotte, MF
    Fillet, G
    Rigo, P
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 147P - 147P
  • [34] SUV-measurements and patient-specific corrections in pediatric Hodgkin-lymphoma: Is there a benefit for PPV in early response assessment by FDG-PET?
    Furth, Christian
    Meseck, Robert M.
    Steffen, Ingo G.
    Schoenberger, Stefan
    Denecke, Timm
    Henze, Guenter
    Hautzel, Hubertus
    Hofheinz, Frank
    Grosser, Oliver
    Hundsdoerfer, Patrick
    Amthauer, Holger
    Ruf, Juri
    PEDIATRIC BLOOD & CANCER, 2012, 59 (03) : 475 - 480
  • [35] The role of FDG-PET in early therapy assessment and follow-up of patients with advanced Hodgkin Lymphoma treated with BEACOPP
    Kahraman, D.
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Mocikova, H.
    Klaskova, K.
    Dedeckova, K.
    Eich, H.
    Boell, B.
    Dietlein, M.
    Kozak, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S251 - S251
  • [36] Assessment of Response to Immunotherapy in Patients with Hodgkin Lymphoma: Towards Quantifying Changes in Tumor Burden Using FDG-PET/CT
    Tutino, Francesca
    Giovannini, Elisabetta
    Chiola, Silvia
    Giovacchini, Giampiero
    Ciarmiello, Andrea
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
  • [37] Response assessment after 4 cycles of beacopp using FDG-PET in patients with advanced-stage hodgkin lymphoma
    Markova, J.
    Kahraman, T. D.
    Kobe, C.
    Skopalova, M.
    Dedeckova, K.
    Gaherova, L.
    Dietlein, M.
    Kozak, T.
    ONKOLOGIE, 2011, 34 : 132 - 132
  • [38] RESPONSE ASSESSMENT AFTER 4 CYCLES OF BEACOPP USING FDG-PET IN PATIENTS WITH ADVANCED-STAGE HODGKIN LYMPHOMA
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Dedeckova, K.
    Mocikova, H.
    Klaskova, K.
    Kahraman, D.
    Dietlein, M.
    Kozak, T.
    ANNALS OF ONCOLOGY, 2011, 22 : 160 - 160
  • [39] Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma
    Hutchings, Martin
    Loft, Annika
    Hansen, Mads
    Berthelsen, Anne Kiil
    Specht, Lena
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (03) : 206 - 212
  • [40] The predictive value of interim FDG-PET in early-stage Hodgkin lymphoma is not well established
    Adams, H. J. A.
    Kwee, T. C.
    ANNALS OF ONCOLOGY, 2018, 29 (02) : 510 - 512
12345